Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression profile of lncRNAs in CSCs and non-CSCs of bladder cancer cell line

ABSTRACT: Expression profile of lncRNAs in CSCs and non-CSCs of bladder cancer cell line

PROVIDER: PRJNA421726 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Expression profile of lncRNAs in CSCs and non-CSCs of bladder cancer cell line

Project description:Bladder cancer stem cells (CSCs) contribute to tumorigenesis, recurrence and chemoresistance of bladder cancer. However, the molecular mechanisms underlying their self-renewal are poorly unknown. Long noncoding RNAs (lncRNAs) act as crucial regulators in a lot of human cancers, yet their potential roles and molecular mechanisms in bladder CSCs are poorly understood. The goal of this study is to identify the differentially expressed lncRNAs in bladder CSCs (UM-UC-3 4th spheres), its two differentiation sublines and bladder non-CSCs (UM-UC-3). Our study reveals that deregulation of lncRNAs is involved in the bladder CSCs.

2019-09-22 | GSE107857 | GEO

Genome-wide analysis of long noncoding RNA and mRNA expression profile in A549 CSCs and non-CSCs

Project description:Lung cancer is the malignant tumor with the highest incidence in the world. Cancer stem cells (CSCs) has the characteristics of immortal proliferation, self-renewal, differentiation of stem cells and high invasion and migration capabilities. In recent years, the function of non-coding RNA (ncRNA) that is regarded as transcription noise has been gradually discovered which can participate in the occurrence and development of tumors by regulating the stemness of cancer stem cells. Herein, we detected the differential expressed lncRNAs in A549 NANOG+ (CSCs) and A549 NANOG- (non-CSCs) cells. Our finding suggest the profiles of lncRNAs changed in CSCs compared with non-CSCs and provide new insight into molecular mechanism that may account for the lung adenocarcinoma.

2022-10-30 | GSE160320 | GEO

Expression profiles of lncRNAs in bladder cancer

Project description:To explore non-coding and coding expression profiling and their biological functions in bladder cancer, we surveyed the lncRNA and mRNA expression signature of bladder cancer and para-cancer tissues using microarray for four patients. Thousands of significantly changed lncRNAs and mRNAs were identified. Our findings provide a novel perspective on transcriptional group and lay the foundation for future research of potential roles of lncRNAs in bladder carcinoma.

2016-10-21 | GSE89006 | GEO

Comparison of gene expression in CSCs (tumorspheres) vs non-CSCs (2D adherent condition) from A13A PDAC cell line

Project description:Comparison of gene expression in CSCs (tumorspheres) vs non-CSCs (2D adherent condition) from A13A PDAC cell line

| PRJNA1022408 | ENA

Comparison of gene expression in CSCs (tumorspheres) vs non-CSCs (2D adherent condition) from A13A PDAC cell line [ATAC-seq]

Project description:Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest and most metastatic cancers in human. PDACs respond poorly to therapies, partly due to cancer stem cells (CSCs) that self-renew, survive chemotherapies, metastasise and replenish the tumor. Factors secreted by tumor cells mediate autocrine/paracrine crosstalk with surrounding cells contributing to the stem cell niche but are still insufficiently characterised. Here we used quantitative SILAC proteomics to identify secreted factors enriched in CSC secretome compared to non-CSCs. Our data uncovered factors that mediate the crosstalk between CSCs and non-CSCs as well as genes mediating the gene expression circuitries regulating CSC proliferation.

2024-02-18 | GSE244326 | GEO

Comparison of gene expression in CSCs (tumorspheres) vs non-CSCs (2D adherent condition) from A13A PDAC cell line [RNA-seq]

2024-02-18 | GSE244287 | GEO

Comparison of gene expression in CSCs (tumorspheres) vs non-CSCs (2D adherent condition) from A13A PDAC cell line [RNA-seq]

Project description:Comparison of gene expression in CSCs (tumorspheres) vs non-CSCs (2D adherent condition) from A13A PDAC cell line [RNA-seq]

| PRJNA1022070 | ENA

Comparison of gene expression in CSCs (tumorspheres) vs non-CSCs (2D adherent condition) from A13A PDAC cell line [ATAC-seq]

Project description:Comparison of gene expression in CSCs (tumorspheres) vs non-CSCs (2D adherent condition) from A13A PDAC cell line [ATAC-seq]

| PRJNA1022410 | ENA

GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy

Project description:Recent studies revealed that treatment resistant cancer stem-like cells (CSCs)/cancer-initiating cells (CICs) can be targeted by cytotoxic T lymphocytes (CTLs). CTLs recognize antigenic peptide derived from tumor-associated antigens (TAAs), thus identification of tumor-associated antigens (TAAs) expressed in CSCs/CICs is essential. Human leucocyte antigen (HLA) ligandome analysis using mass spectrometry enables analysis of naturally expressed antigenic peptides; however, HLA ligandome analysis requires large scale of sample and it is challenging for CSCs/CICs. In this study, we established novel bladder CSC/CIC model from a bladder cancer cell line UM-UC-3 cells using ALDEFLUOR assay. CSCs/CICs were isolated as aldehyde dehydrogenase (ALDH) high cells and several ALDHhigh clone cells were established. ALDHhigh clone cells were enriched with CSCs/CICs by sphere formation and tumorigenicity in immune deficient mouse. HLA ligandome analysis and gene expression (CAGE) using ALDHhigh clone cells revealed distinctive antigenic peptide repertoire in bladder CSCs/CICs, and we identified GRIK2 derived antigenic peptide is specifically expressed in CSCs/CICs. GRIK2 peptide-specific CTL clone recognized GRIK2-overexpressed UM-UC-3 cells and ALDHhigh clone cells indicating that GRIK2 peptide can be a novel target for bladder CSCs/CICs-targeting immunotherapy.

2021-10-01 | GSE166947 | GEO

RNA-seq profiling identifies lncRNAs in serum as potential biomarker for muscle-invasive bladder cancer

Project description:To investigate the expression profiles of lncRNAs in muscle-invasive bladder cancer .

2025-01-08 | GSE255069 | GEO